WNK3 and breast cancer: These data suggest that a minority subpopulation of pre-existing phospho-PR+ breast cancer cells and/or inducible PRs are capable of significantly expanding the therapy-resistant stem-like cell compartment in apparently PR-null but ER+ TamR (i.e. luminal B-type) models.